SCHEMBL6087461

SCHEMBL6087461

Oc1c(-c2ccc(OCc3ccccc3)cc2)ccc2cc(OCc3ccccc3)ccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.56
P2RY14 Q15391 1/20 0.55
GSTP1 P09211 2/20 0.55
LMNA P02545 1/20 0.51
CYP1A2 P05177 1/20 0.51
PTGS1 P23219 1/20 0.51
SLC6A2 P23975 1/20 0.51
CYP2C19 P33261 1/20 0.51
PTGS2 P35354 1/20 0.51
SLC6A3 Q01959 1/20 0.51
HIF1A Q16665 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
MGAM O43451 3/20 0.51
GAA P10253 3/20 0.51
SI P14410 3/20 0.51
MGAM2 Q2M2H8 3/20 0.51
MAPT P10636 4/20 0.50
NPSR1 Q6W5P4 4/20 0.50
MAPK1 P28482 2/20 0.49
KDM4E B2RXH2 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6086405 0.93 LMNA (0.54) ALOX5P2RY14GSTP1LMNACYP1A2
SCHEMBL6086702 0.92 MGAM (0.56) ALOX5P2RY14GSTP1LMNACYP1A2
SCHEMBL6087375 0.92 NPSR1 (0.58) ALOX5P2RY14GSTP1LMNAMGAM
SCHEMBL1359809 0.92 ALOX5 (0.51) ALOX5P2RY14GSTP1MGAMGAA
SCHEMBL6088211 0.89 MCL1 (0.50) ALOX5P2RY14GSTP1MGAMGAA
SCHEMBL6087007 0.89 MCL1 (0.53) ALOX5P2RY14GSTP1LMNACYP1A2
SCHEMBL1360827 0.81 ALOX5 (0.59) ALOX5P2RY14LMNACYP1A2PTGS1
SCHEMBL1358547 0.78 ESR1 (0.56) ALOX5P2RY14GSTP1LMNACYP1A2
SCHEMBL4966110 0.78 MGAM (0.53) ALOX5P2RY14LMNACYP1A2PTGS1
SCHEMBL6668074 0.76 MAOB (0.54) ALOX5P2RY14GSTP1MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7045628-B2 Synthesis of 2-aryl-1-naphthol derivatives via a tandem palladium catalyzed arylation and dehydrogenation ELI LILLY AND COMPANY (US) 2006-05-16 US disclosed
US-20040133047-A1 Synthesis of 2-aryl-1-naphthol derivatives via a tandem palladium catalyzed arylation and dehydrogenation MAY SCOTT ALLAN (US) 2004-07-08 US disclosed
WO-2002044119-A2 SYNTHESIS OF 2-ARYL-1-NAPHTHOL DERIVATIVES VIA A TANDEM PALLADIUM CATALYZED ARYLATION AND DEHYDROGENATION ELI LILLY AND COMPANY (US) 2002-06-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040133047-A1 Synthesis of 2-aryl-1-naphthol derivatives via a tandem palladium catalyzed arylation and dehydrogenation NQO1, CYP1A1, DDT ALOX5 2070/4885P2RY14 4785/4885GSTP1 1717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.